로딩 중…
지수 로딩 중…
Definium Therapeutics, Inc.
DFTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$24.48+0.20%
2026-06-18
Price Chart
Definium Therapeutics, Inc.+245.28%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.67B |
| Revenue | $0.00 |
| Net Income | $-238M |
| Total Assets | $401M |
| Net Assets | $279M |
| Value | |
| P/B | 9.57x |
| FCF Yield | -5.38% |
| Profitability | |
| ROE | -85.19% |
| ROA | -59.19% |
| Financial Health | |
| Debt Ratio | 43.91% |
| Total Debt | $0.00 |
| FCF | $-144M |
| Cash | $263M |
| Current Ratio | 4.69x |
| Performance | |
| 1Y Return | 245.28% |
| 1M Return | 22.28% |
| From 52W High | -6.74% |
| 1Y MDD | -24.79% |
| Trading | |
| Volume | 1,676,010 shares |
| Trading Value | $41M |
| Per Share | |
| EPS | $-2.06 |
| BPS | $3.72 |